Explaining unexplained hypoglycemia: How LC-MS/MS can help
- PMID: 35860389
- PMCID: PMC9289730
- DOI: 10.1016/j.plabm.2022.e00291
Explaining unexplained hypoglycemia: How LC-MS/MS can help
Abstract
Explaining hypoglycaemia, especially in patients without diabetes mellitus, is challenging. Here we present a case, where the added value for clinical diagnosis of insulin determination with liquid chromatography-mass spectrometry (LC-MS/MS) is shown. By the use of LC-MS/MS the different insulin analogues can be identified. The confirmation of an insulin analogue present during hypoglycaemia facilitated in our case the discussion with the patient and his family about what happened.
© 2022 The Authors.
Conflict of interest statement
None.
Figures
References
-
- Cryer P.E., et al. Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2009;94(3):709–728. - PubMed
-
- Mathieu C., Gillard P., Benhalima K. Insulin analogues in type 1 diabetes mellitus: getting better all the time. Nat. Rev. Endocrinol. 2017;13(7):385–399. - PubMed
-
- Parfitt C., et al. Commercial insulin immunoassays fail to detect commonly prescribed insulin analogues. Clin. Biochem. 2015;48(18):1354–1357. - PubMed
-
- Heald A.H., et al. Most commercial insulin assays fail to detect recombinant insulin analogues. Ann. Clin. Biochem. 2006;43:306–308. - PubMed
-
- Heurtault B., et al. Extensive study of human insulin immunoassays: promises and pitfalls for insulin analogue detection and quantification. Clin. Chem. Lab. Med. 2014;52(3):355–362. - PubMed
Publication types
LinkOut - more resources
Full Text Sources